Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Research Article
  • Published:

Comparative sequencing and association studies of aromatic L-amino acid decarboxylase in schizophrenia and bipolar disorder

Abstract

Aromatic L-amino acid decarboxylase (AADC) is a relatively non specific enzyme involved in the biosynthesis of several classical neurotransmitters including dopamine and 5-hydroxytryptamine (5HT; serotonin).1 AADC does not catalyse the rate limiting step in either pathway, but is rate limiting in the synthesis of 2-phenylethylamine (2PE) which is a positive modulator of dopaminergic transmission and a candidate natural psychotogenic compound.1 We and others have proposed that polymorphism in AADC resulting in altered 2PE activity might contribute to the pathogenesis of psychosis.1,2 In order to test this hypothesis, we have used denaturing high performance liquid chromatography (DHPLC)3 to screen 3943 bases of the aadc gene and its promoter regions for variants that might affect protein structure or expression in 15 unrelated people with schizophrenia, and 15 unrelated people with bipolar disorder. three polymorphisms were identified by dhplc: a insertion/deletion polymorphism in the 5′ utr of the neuronal specific mrna (g.-33–30delagag, bases 586–589 of genbank m77828), a t>a variant in the non-neuronal exon 1 (g.-67t>a, genbank m88070), and a g>a polymorphism within intron 8 (g.ivs8 +75g>A, GenBank M84598). Case-control analysis did not suggest that genetic polymorphism in the AADC gene is associated with liability for developing schizophrenia or bipolar disorder.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Berry MD, Juorio AV, Li X-M, Boulton AA . Aromatic L-amino acid decarboxylase: a neglected and misunderstood enzyme Neurochem Res 1996; 21: 1075–1087

    Article  CAS  Google Scholar 

  2. Buckland PR, Spurlock G, McGuffin P . Amphetamine and vigabatrin down regulate aromatic L-amino acid decarboxylase mRNA levels Brain Res Mol Brain Res 1996; 35: 69–76

    Article  CAS  Google Scholar 

  3. Underhill PA, Jin L, Lin AA, Mehdi SQ, Jenkins T, Vollrath D et al. Detection of numerous Y chromosome biallelic polymorphisms by denaturing high performance liquid chromatography (DHPLC) Genome Res 1997; 7: 996–1005

    Article  CAS  Google Scholar 

  4. Sandler M, Reynolds GP . Does phenylethylamine cause schizophrenia? Lancet 1976; 1: 70–71

    Article  CAS  Google Scholar 

  5. Davis BA, Shrikande S, Paralikar VP, Hirsch SR, Durden DA, Boulton AA . Phenylacetic acid in CSF and serum in Indian schizophrenic patients Prog Neuropsychopharmacol Biol Psychiatry 1991; 15: 41–47

    Article  CAS  Google Scholar 

  6. O'Reilly R, Davis BA, Durden DA, Thorpe L, Machnee H, Boulton AA . Plasma phenylethylamine in schizophrenic patients Biol Psychiatry 1991; 30: 145–150

    Article  CAS  Google Scholar 

  7. Reith J, Benkelfat C, Sherwin A, Yasuhara Y, Kuwabara H, Andermann F et al. Elevated dopa decarboxylase activity in living brain of patients with psychosis Proc Natl Acad Sci USA 1994; 91: 11651–11654

    Article  CAS  Google Scholar 

  8. Buckland PR, O'Donovan MC, McGuffin P . Changes in dopa decarboxylase mRNA but not tyrosine hydroxylase mRNA levels in rat brain following antipsychotic treatment Psychopharmacology 1992; 108: 98–102

    Article  CAS  Google Scholar 

  9. Buckland PR, Marshall R, Watkins P, McGuffin P . Does phenylethylamine have a role in schizophrenia? LSD and PCP up-regulate aromatic L-amino acid decarboxylase mRNA levels Brain Res Mol Brain Res 1997; 49: 266–270

    Article  CAS  Google Scholar 

  10. Sobell JL, Heston LL, Sommer SS . Delineation of genetic predisposition to multifactorial disease: a general approach on the threshold of feasibility Genomics 1992; 12: 1–6

    Article  CAS  Google Scholar 

  11. Sumi-Ichinose C, Ichinose H, Takahashi E, Hori T, Nagatsu T . Molecular cloning of genomic and chromosomal assignment of the gene for human aromatic L-amino acid decarboxylase, the enzyme for catecholamine and serotonin biosynthesis Biochemistry 1992; 31: 2229–2238

    Article  CAS  Google Scholar 

  12. Chireux M, Raynal JF, Le Van Thai A, Cadas H, Bernard C, Martinou I et al. Multiple promoters of human choline acetyltransferase and aromatic L-amino acid decarboxylase genes J Physiol Paris 1994; 88: 215–227

    Article  CAS  Google Scholar 

  13. O'Donovan MC, Oefner PJ, Roberts SC, Austin J, Hoogendoorn B, Guy C et al. Blind analysis of denaturing high performance liquid chromatography as a tool for mutation detection Genomics 1998; 52: 44–49

    Article  CAS  Google Scholar 

  14. Jones A, Austin J, Hansen N, Hoogendoorn B, Oefner PJ, Cheadle JP et al. Optimal temperature selection for mutation detection by denaturing HPLC and comparison to single-stranded conformation polymorphism and heteroduplex analysis Clin Chem 1999; 45: 1133–1140

    CAS  PubMed  Google Scholar 

  15. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders (4th edition) American Psychiatric Association: Washington DC 1994

    Google Scholar 

  16. McGuffin P, Farmer A, Harvey I . A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system Arch Gen Psychiatry 1991; 48: 764–770

    Article  CAS  Google Scholar 

  17. Wing JK, Cooper JE, Sartorius N . Measurement and Classification of Psychiatric Symptoms Cambridge University Press: Cambridge 1972

    Google Scholar 

  18. Wing JK, Babor T, Brugha T, Burke J, Cooper JE, Giel R et al. SCAN: Schedules for clinical assessment in neuropsychiatry Arch Gen Psychiatry 1990; 47: 589–593

    Article  CAS  Google Scholar 

  19. Owen MJ, Holmans P, McGuffin P . Association studies in psychiatric genetics Mol Psychiatry 1997; 2: 270–273

    Article  CAS  Google Scholar 

  20. O'Donovan MC, Guy C, Craddock N, Bowen T, McKeon P, Macedo A et al. Confirmation of association between expanded CAG/CTG repeats and both schizophrenia and bipolar disorder Psychol Med 1996; 26: 1145–1153

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by a grant from the Wellcome Trust (052309) and an MRC Programme Grant (G9309834). J Austin is funded by a University of Wales College of Medicine Studentship. Ian Jones is a Wellcome Trust Research Fellow in Mental Health. Nick Craddock is a Wellcome Trust Senior Research Fellow in Clinical Sciences.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M C O'Donovan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Speight, G., Turic, D., Austin, J. et al. Comparative sequencing and association studies of aromatic L-amino acid decarboxylase in schizophrenia and bipolar disorder. Mol Psychiatry 5, 327–331 (2000). https://doi.org/10.1038/sj.mp.4000717

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.mp.4000717

Keywords

This article is cited by

Search

Quick links